AnGes, Inc. (4563.T)

JPY 72.0

(2.86%)

Total Debt Summary of AnGes, Inc.

  • AnGes, Inc.'s latest annual total debt in 2023 was 362.67 Million JPY , down -68.62% from previous year.
  • AnGes, Inc.'s latest quarterly total debt in 2024 Q2 was 335.59 Million JPY , down -4.73% from previous quarter.
  • AnGes, Inc. reported annual total debt of 1.15 Billion JPY in 2022, down 0.0% from previous year.
  • AnGes, Inc. reported annual total debt of - JPY in 2021, down 0.0% from previous year.
  • AnGes, Inc. reported quarterly total debt of 352.23 Million JPY for 2024 Q1, down -2.88% from previous quarter.
  • AnGes, Inc. reported quarterly total debt of 1.08 Billion JPY for 2023 Q1, down -5.88% from previous quarter.

Annual Total Debt Chart of AnGes, Inc. (2023 - 2008)

Historical Annual Total Debt of AnGes, Inc. (2023 - 2008)

Year Total Debt Total Debt Growth
2023 362.67 Million JPY -68.62%
2022 1.15 Billion JPY 0.0%
2021 - JPY 0.0%
2020 - JPY 0.0%
2019 - JPY 0.0%
2018 - JPY 0.0%
2017 - JPY 0.0%
2016 - JPY 0.0%
2015 - JPY 0.0%
2014 - JPY 0.0%
2013 - JPY 0.0%
2012 - JPY 0.0%
2011 - JPY 0.0%
2010 - JPY 0.0%
2009 - JPY 0.0%
2008 - JPY 0.0%

Peer Total Debt Comparison of AnGes, Inc.

Name Total Debt Total Debt Difference
KOHJIN BIO CO LTD 2.46 Billion JPY 85.315%
PRISM BioLab Co.,LTD - JPY -Infinity%
GNI Group Ltd. 3.69 Billion JPY 90.196%
Linical Co., Ltd. 3 Billion JPY 87.918%
Trans Genic Inc. 2.25 Billion JPY 83.932%
MEDINET Co., Ltd. 2.3 Million JPY -15620.633%
Soiken Holdings Inc. - JPY -Infinity%
Cytori Cell Research Institute, Inc. 2.47 Billion JPY 85.327%
OncoTherapy Science, Inc. 106.84 Million JPY -239.428%
Nxera Pharma Co., Ltd. 73.97 Billion JPY 99.51%
Immuno-Biological Laboratories Co., Ltd. 235.98 Million JPY -53.688%
NanoCarrier Co., Ltd. 1.1 Billion JPY 67.295%
Carna Biosciences, Inc. 182.97 Million JPY -98.214%
CanBas Co., Ltd. - JPY -Infinity%
D. Western Therapeutics Institute, Inc. 885.12 Million JPY 59.025%
RaQualia Pharma Inc. 367.71 Million JPY 1.371%
Chiome Bioscience Inc. 291 Million JPY -24.631%
Kidswell Bio Corporation 2.57 Billion JPY 85.916%
PeptiDream Inc. 22.79 Billion JPY 98.409%
Oncolys BioPharma Inc. 315.17 Million JPY -15.073%
Ribomic Inc. - JPY -Infinity%
SanBio Company Limited 665 Million JPY 45.462%
Healios K.K. 4.53 Billion JPY 91.997%
BrightPath Biotherapeutics Co., Ltd. 112.5 Million JPY -222.378%
Kubota Pharmaceutical Holdings Co., Ltd. 142.85 Million JPY -153.88%
Delta-Fly Pharma, Inc. - JPY -Infinity%
StemRIM - JPY -Infinity%
CellSource Co., Ltd. 97.54 Million JPY -271.814%
FunPep Company Limited - JPY -Infinity%
Kringle Pharma, Inc. - JPY -Infinity%
Stella Pharma Corporation 933.3 Million JPY 61.141%
TMS Co., Ltd. - JPY -Infinity%
Noile-Immune Biotech Inc. - JPY -Infinity%
Cuorips Inc. - JPY -Infinity%
K Pharma,Inc. - JPY -Infinity%
Takara Bio Inc. 968 Million JPY 62.534%
ReproCELL Incorporated - JPY -Infinity%
PhoenixBio Co., Ltd. 723.93 Million JPY 49.902%
StemCell Institute Inc. 8.78 Million JPY -4028.814%
Japan Tissue Engineering Co., Ltd. - JPY -Infinity%
CellSeed Inc. 151.25 Million JPY -139.785%